FDA Approves New Type of Flu Vaccine for Seniors
· Telemundo McAllen (KTLM)
The FDA has approved a new flu vaccine for seniors, named mFlusiva, developed using the same mRNA technology that was crucial in combating the COVID-19 pandemic, according to Moderna. This vaccine is intended for adults aged 50 and older. While other flu vaccines are already available in pharmacies for the upcoming fall vaccination season, mFlusiva is expected to be available soon. The FDA granted full approval for its use in individuals aged 50 to 64 based on a study showing a 27% reduction in flu cases compared to another brand. For those 65 and older, it received accelerated approval, pending further studies. Side effects were mostly mild and temporary, including pain at the injection site and fatigue.
AI summary · Source: Telemundo McAllen (KTLM) →
